Risk factors for neutropenia and febrile neutropenia following prophylactic pegfilgrastim-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk factors for neutropenia and febrile neutropenia following prophylactic pegfilgrastim

Published:2019-04-17 Issue: Volume: Page:
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia‐Pac J Clin Oncol

Author:

Lee Mirinae¹²,Yee Jeong³,Kim Jae Youn²,Kim Ju Young⁴,An Sook Hee⁵,Lee Kyung Eun⁴,Gwak Hye Sun³^ORCID

Affiliation:

1. Graduate School of Converging Clinical & Public HealthEwha Womans University Seoul Korea

2. Department of PharmacyAsan Medical Center Seoul Korea

3. College of Pharmacy & Division of Life and Pharmaceutical SciencesEwha Womans University Seoul Korea

4. College of PharmacyChungbuk National University Cheongju‐si Korea

5. College of PharmacyWonkwang University Jeonbuk Korea

Funder

Chungbuk National University

National Research Foundation of Korea

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13152

Reference20 articles.

1. Severe neutropenia: a diagnostic approach;Munshi HG;West J Med,2000

2. Pegfilgrastim and daily granulocyte colony‐stimulating factor: patterns of use and neutropenia‐related outcomes in cancer patients in Spain–results of the LEARN Study;Almenar D;Eur J Cancer Care (Engl),2009

3. Days of prophylactic filgrastim use to reduce febrile neutropenia in patients with non‐Hodgkin's lymphoma treated with chemotherapy;Scott SD;J Manag Care Pharmacy,2003

4. G‐CSF and GM‐CSF in Neutropenia;Mehta HM;J Immunol,2015

5. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America;Freifeld AG;Clin Infect Dis,2011

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Factors for Eribulin-induced Severe Neutropenia in Patients With Recurrent Breast Cancer;In Vivo;2023-12-25

2. Profiling risk factors for separation of infection complications in patients with gastrointestinal and nodal diffuse large B-cell lymphoma;BMC Infectious Diseases;2023-10-20

3. Pegfilgrastim OBI device use for neutropenia prevention: a scoping review;Acta Paulista de Enfermagem;2023-08-09

4. Inflammation Control and Tumor Growth Inhibition of Ovarian Cancer by Targeting Adhesion Molecules of E-Selectin;Cancers;2023-04-04

5. Uso do dispositivo Pegfilgrastim OBI para prevenção de neutropenia: revisão de escopo;Acta Paulista de Enfermagem;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3